77:
169:
275:
Incandela, L; Belcaro, G; Renton, S; Desanctis, MT; Cesarone, MR; Bavera, P; Ippolito, E; Bucci, M; et al. (2002). "HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: A prospective, placebo-controlled, randomized trial".
341:
Gulati, OP; Nordmann, H; Aellig, A; Maignan, MF; McGinness, J (1985). "Protective effects of O-(beta-hydroxyethyl)-rutosides (HR) against adriamycin-induced toxicity in rats".
178:
Relvène (1967 French version), Venoruton (1962 Swiss version), and
Paroven are mixtures of hydroxyethyl rutinosides. Hydroxyethylrutosides are used in the treatment of
87:
386:
220:
148:
120:
127:
745:
740:
379:
59:
Oxerutins are semisynthetic derivatives of plant constituents. Although they are closely related to the natural flavonoid
179:
134:
618:
116:
95:
232:
Frick, RW (2000). "Three treatments for chronic venous insufficiency: Escin, hydroxyethylrutoside, and Daflon".
372:
53:
603:
106:
91:
43:
458:
27:
613:
585:
141:
641:
301:
257:
190:
350:
329:
293:
249:
63:, hydroxyethylrutosides are not found in food. The only way to take them is in a supplement.
474:
285:
241:
443:
183:
575:
419:
395:
189:
Hydroxyethylrutosides have been used as an alternative to horse chestnut preparations (
318:
734:
453:
448:
438:
261:
545:
463:
433:
399:
305:
24:
186:. Oxerutins work by reducing leakage from the small blood vessels (capillaries).
710:
677:
608:
531:
498:
38:
289:
245:
715:
687:
570:
560:
513:
508:
493:
488:
408:
330:
The handbook of clinically tested herbal remedies, Volume 2 by
Marilyn Barrett
201:
48:
692:
663:
483:
297:
253:
354:
503:
428:
31:
364:
682:
580:
556:
105:
if you can. Unsourced or poorly sourced material may be challenged and
623:
194:
672:
60:
368:
70:
343:
278:
197:. Typical doses are in the order of 1,000 mg/day.
102:
701:
661:
654:
632:
594:
554:
544:
522:
472:
417:
407:
204:-induced toxicity have been investigated in rats.
101:Please review the contents of the section and
23:-beta-hydroxyethyl-rutosides, HR, or HER) are
380:
8:
658:
551:
414:
387:
373:
365:
200:Effects of hydroxyethylrutosides against
213:
596:sclerosing agents for local injection
7:
221:Oxerutins on healthlibrary.epnet.com
14:
167:
75:
103:add the appropriate references
1:
655:Capillary stabilising agents
180:chronic venous insufficiency
88:reliable medical references
762:
319:Paroven on netdoctor.co.uk
290:10.1177/107424840200700103
246:10.1177/000331970005100303
619:Sodium tetradecyl sulfate
94:or relies too heavily on
54:Tetrahydroxyethylrutoside
604:Monoethanolamine oleate
459:Fluocinolone acetonide
117:"Hydroxyethylrutoside"
44:Dihydroxyethylrutoside
17:Hydroxyethylrutosides
746:Flavonol rutinosides
741:Quercetin glycosides
614:Inverted sugar syrup
586:Pentosan polysulfate
34:. Examples include:
284:(Suppl 1): S7–S10.
642:Calcium dobesilate
728:
727:
724:
723:
650:
649:
571:Organo-heparinoid
540:
539:
475:local anesthetics
409:Antihemorrhoidals
182:and hypertensive
176:
175:
152:
753:
659:
552:
415:
389:
382:
375:
366:
359:
358:
338:
332:
327:
321:
316:
310:
309:
272:
266:
265:
229:
223:
218:
171:
170:
162:
159:
153:
151:
110:
79:
78:
71:
761:
760:
756:
755:
754:
752:
751:
750:
731:
730:
729:
720:
697:
646:
628:
590:
563:for topical use
536:
518:
468:
444:Fluorometholone
420:corticosteroids
411:for topical use
403:
396:Vasoprotectives
393:
363:
362:
340:
339:
335:
328:
324:
317:
313:
274:
273:
269:
231:
230:
226:
219:
215:
210:
184:microangiopathy
172:
168:
163:
157:
154:
111:
100:
96:primary sources
80:
76:
69:
67:Health benefits
12:
11:
5:
759:
757:
749:
748:
743:
733:
732:
726:
725:
722:
721:
719:
718:
713:
707:
705:
699:
698:
696:
695:
690:
685:
680:
675:
669:
667:
656:
652:
651:
648:
647:
645:
644:
638:
636:
630:
629:
627:
626:
621:
616:
611:
606:
600:
598:
592:
591:
589:
588:
583:
578:
576:Sodium apolate
573:
567:
565:
549:
542:
541:
538:
537:
535:
534:
528:
526:
520:
519:
517:
516:
511:
506:
501:
496:
491:
486:
480:
478:
470:
469:
467:
466:
461:
456:
451:
446:
441:
436:
431:
429:Hydrocortisone
425:
423:
412:
405:
404:
394:
392:
391:
384:
377:
369:
361:
360:
333:
322:
311:
267:
240:(3): 197–205.
224:
212:
211:
209:
206:
174:
173:
166:
164:
83:
81:
74:
68:
65:
57:
56:
51:
46:
41:
13:
10:
9:
6:
4:
3:
2:
758:
747:
744:
742:
739:
738:
736:
717:
714:
712:
709:
708:
706:
704:
700:
694:
691:
689:
686:
684:
681:
679:
676:
674:
671:
670:
668:
666:
665:
664:bioflavonoids
660:
657:
653:
643:
640:
639:
637:
635:
631:
625:
622:
620:
617:
615:
612:
610:
607:
605:
602:
601:
599:
597:
593:
587:
584:
582:
579:
577:
574:
572:
569:
568:
566:
564:
562:
558:
553:
550:
547:
543:
533:
530:
529:
527:
525:
521:
515:
512:
510:
507:
505:
502:
500:
497:
495:
492:
490:
487:
485:
482:
481:
479:
477:
476:
471:
465:
462:
460:
457:
455:
454:Dexamethasone
452:
450:
449:Fluocortolone
447:
445:
442:
440:
439:Betamethasone
437:
435:
432:
430:
427:
426:
424:
422:
421:
416:
413:
410:
406:
401:
397:
390:
385:
383:
378:
376:
371:
370:
367:
356:
352:
349:(2): 323–34.
348:
344:
337:
334:
331:
326:
323:
320:
315:
312:
307:
303:
299:
295:
291:
287:
283:
279:
271:
268:
263:
259:
255:
251:
247:
243:
239:
235:
228:
225:
222:
217:
214:
207:
205:
203:
198:
196:
193:) containing
192:
187:
185:
181:
165:
161:
158:February 2019
150:
147:
143:
140:
136:
133:
129:
126:
122:
119: –
118:
114:
113:Find sources:
108:
104:
98:
97:
93:
89:
84:This section
82:
73:
72:
66:
64:
62:
55:
52:
50:
47:
45:
42:
40:
37:
36:
35:
33:
29:
26:
22:
18:
702:
662:
633:
595:
555:
546:Antivaricose
523:
473:
464:Fluocinonide
434:Prednisolone
418:
346:
342:
336:
325:
314:
281:
277:
270:
237:
233:
227:
216:
199:
188:
177:
155:
145:
138:
131:
124:
112:
92:verification
85:
58:
25:hydroxyethyl
20:
19:(oxerutins,
16:
15:
711:Tribenoside
678:Monoxerutin
609:Polidocanol
561:heparinoids
532:Tribenoside
86:needs more
39:Monoxerutin
28:derivatives
735:Categories
716:Etamsylate
688:Troxerutin
514:Pramocaine
509:Oxetacaine
494:Benzocaine
489:Tetracaine
208:References
202:adriamycin
191:venostasin
128:newspapers
49:Troxerutin
693:Hidrosmin
499:Dibucaine
484:Lidocaine
234:Angiology
32:rutosides
673:Rutoside
557:heparins
504:Procaine
298:12011966
262:19421726
254:10744007
683:Diosmin
581:Heparin
548:therapy
355:4004421
306:9720685
142:scholar
107:removed
624:Phenol
353:
304:
296:
260:
252:
195:aescin
144:
137:
130:
123:
115:
703:other
634:other
524:other
302:S2CID
258:S2CID
149:JSTOR
135:books
61:rutin
351:PMID
294:PMID
250:PMID
121:news
90:for
559:or
400:C05
347:273
286:doi
242:doi
30:of
737::
345:.
300:.
292:.
280:.
256:.
248:.
238:51
236:.
109:.
402:)
398:(
388:e
381:t
374:v
357:.
308:.
288::
282:7
264:.
244::
160:)
156:(
146:·
139:·
132:·
125:·
99:.
21:O
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.